Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Serena Bazzurri
Observed names:
BAZZURRI, SERENA,
S. Bazzurri
Institution:
Hospital of Prato
Observed institutions:
Ospedale Santa Maria alle Scotte,
Ospedale di Prato Santo Stefano,
Azienda Usl Toscana Centro,
Azienda Ospedaliera Universitaria Pisana,
Hospital of Prato
OpenAlex ID:
A5063484686
The prognostic value of CD3+ tumor-infiltrating lymphocytes for stage II colon cancer according to use of adjuvant chemotherapy: A large single-institution cohort study
2020
·
Edoardo Francini
, Fang-Shu Ou
, et al.
·
Translational Oncology
·
17
PDF
Clinical, molecular, and immunological responses to pembrolizumab treatment of synchronous melanoma and acute myeloid leukemia
2018
·
Anne Sophie Kubasch
, Rebekka Wehner
, et al.
·
Blood Advances
·
10
PDF
The observational EURACAN prospective clinical registry dedicated to epithelioid hemangioendothelioma: The protocol of an international and collaborative effort on an ultra-rare entity
2024
·
Anna Maria Frezza
, Hugh Leonard
, et al.
·
PLoS ONE
·
5
Comparison Between First Line Target Therapy and Immunotherapy in Different Prognostic Categories of BRAF Mutant Metastatic Melanoma Patients: An Italian Melanoma Intergroup Study
2022
·
Riccardo Marconcini
, Paolo Fava
, et al.
·
Frontiers in Oncology
·
3
PDF
Safety and Tolerability of COVID-19 Vaccines in Patients with Cancer: A Single Center Retrospective Analysis
2022
·
Amedeo Nuzzo
, Simona Manacorda
, et al.
·
Vaccines
·
2
PDF
Activity of chemotherapy in mesenchymal chondrosarcoma: a multicentre retrospective analysis within the Italian Sarcoma Group network
2026
·
G.G. Baldi
, A.M. Frezza
, et al.
·
ESMO Open
·
1
750P Safety and efficacy of platinum desensitization treatment in patients with ovarian cancer and platinum hypersensitivity
2021
·
A. Nuzzo
, S. Manacorda
, et al.
·
Annals of Oncology
PDF
1045P Comparison between first-line target therapy and immunotherapy in different prognostic categories of BRAF mutant metastatic melanoma patients
2021
·
R. Marconcini
, P. Fava
, et al.
·
Annals of Oncology
CD3+ tumor-infiltrating lymphocytes (TILs) as prognostic in patients (pts) with stage II colon cancer (CC) not treated with adjuvant chemotherapy (ADJ).
2020
·
Edoardo Francini
, Fang-Shu Ou
, et al.
·
Journal of Clinical Oncology
Practical approach to the management of clinical studies during the covid-19 emergency in a large academic hospital
2020
·
Francesco Bloise
, Andrea Sbrana
, et al.
·
Tumori
Primary pleomorphic sarcoma (PS) and leiomyosarcoma (LMS) of bone: Retrospective analysis of an original series
2017
·
G.G. Baldi
, A. Franchi
, et al.
·
Annals of Oncology
PDF
Show more works
View as search
Works count:
12
Citation count:
38
H-index:
3
I10-index:
2
Year
Topic
Type